Placenta accreta spectrum disorders clinical practice guidelines: A systematic review.
AGREE-II
guidelines
placenta accreta spectrum
ultrasound
Journal
The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
28
09
2022
accepted:
28
12
2022
medline:
3
5
2023
pubmed:
17
2
2023
entrez:
16
2
2023
Statut:
ppublish
Résumé
To objectively assess the quality of the published clinical practice guidelines (CPGs) on the management of pregnancies complicated by placenta accreta spectrum (PAS)disorders. MEDLINE, Embase, Scopus, and ISI Web of Science databases were searched. The following aspects related to the management of pregnancies with suspected PAS disorders were evaluated: risk factors for PAS, prenatal diagnosis, role of interventional radiology and ureteral stenting, and optimal surgical management. The assessment of risk of bias and quality assessment of the CPGs were performed using the (AGREE II) tool (Brouwers et al., 2010). To define a CPG as of good quality we adopted a cut-off score >60%. Nine CPGs were included. Specific risk factors for referral were assessed by 44.4% (4/9) of CPGs, mainly consisting in the presence of placenta previa and a prior cesarean delivery or uterine surgery. About 55.6% of CPGs (5/9) suggested ultrasound assessment of women with risk factors for PAS in the second and third trimester of pregnancy and 33.3% (3/9) recommended magnetic resonance imaging (MRI); 88.9% (8/9) of CPGs recommended cesarean delivery at 34-37 weeks of gestation. There was not generally consensus on the use of interventional radiology and ureteral stenting before surgery for PAS. Finally, hysterectomy was the recommend surgical approach by 77.8% (7/9) of the included CPGs. Most of the published CPGs on PAS are generally of good quality. There was general agreement among the different CPGs on PAS as a regard as risk stratification, timing at diagnosis and delivery but not on the indication for MRI, use of interventional radiology and ureteral stenting.
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1313-1321Informations de copyright
© 2023 Japan Society of Obstetrics and Gynecology.
Références
Fonseca A, De Campos DA. Maternal morbidity and mortality due to placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2021;72:84-91. https://doi.org/10.1016/j.bpobgyn.2020.07.011
D'Antonio F, Palacios-Jaraquemada JM, Timor-Trisch I, Cali G. Placenta accreta spectrum disorders: prenatal diagnosis still lacks clinical correlation. Acta Obstet Gynecol Scand. 2018;97(7):773-5. https://doi.org/10.1111/aogs.13374
Iacovelli A, Liberati M, Khalil A, Timor-Trisch I, Leombroni M, Buca D, et al. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2020;33(3):471-81. https://doi.org/10.1080/14767058.2018.1493453
Buca D, Liberati M, Calì G, Forlani F, Caisutti C, Flacco ME, et al. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;52(3):304-9. https://doi.org/10.1002/uog.19070
Hobson SR, Kingdom JC, Murji A, Windrim RC, Carvalho JCA, Singh SS, et al. No. 383-screening, diagnosis, and management of placenta accreta spectrum disorders. J Obstet Gynaecol Can. 2019;41(7):1035-49. https://doi.org/10.1016/j.jogc.2018.12.004
Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort MA, FIGO Placenta accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: non conservative surgical management. Int J Gynaecol Obstet. 2018;140(3):281-90. https://doi.org/10.1002/ijgo.12409
Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int J Gynaecol Obstet. 2018;140(3):265-73. https://doi.org/10.1002/ijgo.12407
Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet. 2018;140(3):291-8. https://doi.org/10.1002/ijgo.12410
Jauniaux E, de Campos DA, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: introduction. Int J Gynaecol Obstet. 2018;140(3):261-4. https://doi.org/10.1002/ijgo.12406
Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274-80. https://doi.org/10.1002/ijgo.12408
Jauniaux ERM, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta praevia and placenta accreta: diagnosis and management. BJOG. 2019;126(1):e1-e48. https://doi.org/10.1111/1471-0528.15306
Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfmorg, Gyamfi-Bannerman C. Consult series #44: management of bleeding in the late preterm period. Am J Obstet Gynecol. 2018;218(1):B2-8. https://doi.org/10.1016/j.ajog.2017.10.019
Hecht JL, Baergen R, Ernst LM, Katzman PJ, Jacques SM, Jauniaux E, et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol. 2020;33(12):2382-96. https://doi.org/10.1038/s41379-020-0569-1
Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR, Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine. Placenta Accreta Spectrum. Am J Obstet Gynecol. 2018;219(6):B2-B16. https://doi.org/10.1016/j.ajog.2018.09.042
Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, Braun T, Calda P, et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019;220(6):511-26. https://doi.org/10.1016/j.ajog.2019.02.054
Acretismo placentario. Sociedad Española de Ginecología y Obstetricia(SEGO), actualizada noviembre 2012.
de Salud M, del Ecuador P. Anomalías de inserción placentaria y vasos sanguíneos fetales. Guía de práctica clínica. Quito: Ministerio de Salud Pública, Dirección Nacional de Normatización; 2017 CDU: 614+618(866).
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. https://doi.org/10.1136/bmj.b2700
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839-42. https://doi.org/10.1503/cmaj.090449
Amer YS, Titi MA, Godah MW, et al. International alliance and agreement of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review. J Clin Epidemiol. 2021;S0895-4356(21):363-2. https://doi.org/10.1016/j.jclinepi.2021.11.010
DI Girolamo R, Buca D, Galliani C, D'Amico A, Calì G, Lucidi A, et al. Systematic review and meta-analysis on placenta accreta spectrum disorders in twin pregnancies: risk factors, detection rate and histopathology. Minerva Obstet Gynecol. 2021. https://doi.org/10.23736/S2724-606X.21.04886-7
Cali G, Labate F, Cucinella G, Fabio M, Buca D, Di Girolamo R, et al. Placenta accreta spectrum disorders in twin pregnancies as an under reported clinical entity: a case series and systematic review. J Matern Fetal Neonatal Med. 2022;35:8848-51. https://doi.org/10.1080/14767058.2021.2005568
Tinari S, Buca D, Cali G, Timor-Tritsch I, Palacios-Jaraquemada J, Rizzo G, et al. Systematic review and meta-analysis of posterior placenta accrete spectrum disorders: risk factors, histopathology and diagnostic accuracy. Ultrasound Obstet Gynecol. 2020;56:269. https://doi.org/10.1002/uog.22183
Calí G, Timor-Tritsch IE, Forlani F, Palacios-Jaraquemada J, Monteagudo A, Kaelin Agten A, et al. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accrete spectrum disorder and surgical outcome. Ultrasound Obstet Gynecol. 2020;55(4):450-9. https://doi.org/10.1002/uog.21939 Erratum in: Ultrasound Obstet Gynecol 2020 Jun;55(6):892. PMID: 31788885.
Cali G, Forlani F, Foti F, Minneci G, Manzoli L, Flacco ME, et al. Diagnostic accuracy of first-trimester ultrasound in detecting abnormally invasive placenta in high-risk women with placenta previa. Ultrasound Obstet Gynecol. 2018;52(2):258-64. https://doi.org/10.1002/uog.19045
Calì G, Calagna G, Khalil A, Polito S, Labate F, Cucinella G, et al. First-trimester prediction of uterine rupture in cesarean scar pregnancy. Am J Obstet Gynecol. 2022;227(2):353-5. https://doi.org/10.1016/j.ajog.2022.04.026
D'Antonio F, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteagudo A, Buca D, Forlani F, et al. First-trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(2):176-83. https://doi.org/10.1002/uog.18840
Palacios-Jaraquemada JM, D'Antonio F, Buca D, Fiorillo A, Larraza P. Systematic review on near miss cases of placenta accrete spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome. J Matern Fetal Neonatal Med. 2020;33(19):3377-84. https://doi.org/10.1080/14767058.2019.1570494
Pagani G, Cali G, Acharya G, Trisch IT, Palacios-Jaraquemada J, Familiari A, et al. Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018;97(1):25-37. https://doi.org/10.1111/aogs.13238
Cali G, Forlani F, Lees C, Timor-Tritsch I, Palacios-Jaraquemada J, Dall'Asta A, et al. Prenatal ultrasound staging system for placenta accreta spectrum disorders. Ultrasound Obstet Gynecol. 2019;53(6):752-60. https://doi.org/10.1002/uog.20246
Dall'Asta A, Calì G, Forlani F, Paramasivam G, Girardelli S, Yazbek J, et al. Evaluation of perioperative complications using a newly described staging system for placenta accreta spectrum. Eur J Obstet Gynecol Reprod Biol. 2020;250:54-60. https://doi.org/10.1016/j.ejogrb.2020.04.038
Calì G, Timor-Trisch IE, Palacios-Jaraquemada J, Monteaugudo A, Forlani F, Minneci G, et al. Changes in ultrasonography indicators of abnormally invasive placenta during pregnancy. Int J Gynaecol Obstet. 2018;140(3):319-25. https://doi.org/10.1002/ijgo.12413
Timor-Tritsch IE, Monteagudo A, Cali G, Vintzileos A, Viscarello R, Al-Khan A, et al. Cesarean scar pregnancy is a precursor of morbidly adherent placenta. Ultrasound Obstet Gynecol. 2014;44(3):346-53. https://doi.org/10.1002/uog.13426
Timor-Tritsch IE, Monteagudo A, Cali G, Palacios-Jaraquemada JM, Maymon R, Arslan AA, et al. Cesarean scar pregnancy and early placenta 13ccrete share common histology. Ultrasound Obstet Gynecol. 2014;43(4):383-95. https://doi.org/10.1002/uog.13282
Timor-Tritsch IE, Monteagudo A, Calì G, D'Antonio F, Kaelin AA. Cesarean scar pregnancy: diagnosis and pathogenesis. Obstet Gynecol Clin N Am. 2019;46(4):797-811. https://doi.org/10.1016/j.ogc.2019.07.009
Timor-Tritsch IE, D'Antonio F, Calí G, Palacios-Jaraquemada J, Meyer J, Monteagudo A. Early first-trimester transvaginal ultrasound is indicated in pregnancy after previous cesarean delivery: should it be mandatory? Ultrasound Obstet Gynecol. 2019;54(2):156-63. https://doi.org/10.1002/uog.20225
Finazzo F, D'antonio F, Masselli G, Forlani F, Palacios-Jaraquemada J, Minneci G, et al. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders. Ultrasound Obstet Gynecol. 2020;55(4):467-73. https://doi.org/10.1002/uog.20381
Familiari A, Liberati M, Lim P, Pagani G, Cali G, Buca D, et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018;97(5):507-20. https://doi.org/10.1111/aogs.13258
Palacios-Jaraquemada JM, Bruno CH. Utility of MRI in placenta Accreta Spectrum for the surgical team. AJR Am J Roentgenol. 2021;217(5):1257. https://doi.org/10.2214/AJR.21.26325
Palacios Jaraquemada JM, Pesaresi M, Nassif JC, Hermosid S. Anterior placenta percreta: surgical approach, hemostasis and uterine repair. Acta Obstet Gynecol Scand. 2004;83(8):738-44. https://doi.org/10.1111/j.0001-6349.2004.00517.x
D'Antonio F, Iacovelli A, Liberati M, Leombroni M, Murgano D, Cali G, et al. Role of interventional radiology in pregnancy complicated by placenta accreta spectrum disorder: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019;53(6):743-51. https://doi.org/10.1002/uog.20131
Chandraharan E, Rao S, Belli AM, Arulkumaran S. The triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet. 2012;117(2):191-4. https://doi.org/10.1016/j.ijgo.2011.12.005
Di Mascio D, Calì G, D'antonio F. Updates on the management of placenta accrete spectrum. Minerva Ginecol. 2019;71(2):113-20. https://doi.org/10.23736/S0026-4784.18.04333-2
Jauniaux E, Kingdom JC, Silver RM. A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2021;72:102-16. https://doi.org/10.1016/j.bpobgyn.2020.06.007